If you need help accessing our website, call 855-698-9991
Skip to main content
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Carol M. Lee, MD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Retinal Ophthalmology, Ophthalmology
  • Treats: Adults
  • Languages: English, Korean
  • Phone: 212-684-2424
View Locations

Conditions and Treatments

For Adults
Conditions
  • diabetic retinopathy
  • uveitis
Treatments
  • laser surgery
  • retinal surgery
  • vitrectomy

Positions
Board Certifications
  • American Board of Ophthalmology - Ophthalmology, 1991
Education and Training
  • Fellowship, Washington University Medical Center, Vitreoretinal Surgery, 1991
  • Residency, NYU Medical Center, Ophthalmology, 1989
  • Fellowship, University of Illinois Hospital and Clinics, Retina, 1986
  • MD from SUNY-Downstate, 1984

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Empire Blue Cross Blue Shield
     
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Oxford
     
    • Oxford Freedom
  • UHC
     
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Carol M. Lee, MD does not accept insurance.

Locations and Appointments

Carol M. Lee, M.D.

161 Madison Ave, Ste 5NE, New York, NY 10016

View Map
Phone

212-684-2424

Fax

212-448-0116

Carol M. Lee, M.D.

530 1st Ave, Ste 3B, New York, NY 10016

View Map
Phone

212-684-2424

Fax

212-576-2579

  • Nivolumab will be investigated at the Food and Drug Administration (FDA)-approved dose of 480 mg intravenous (IV) every 4 weeks until unacceptable toxicity disease progression or completion of 2 years of therapy. If that dose and schedule have unaccepta

    Learn More

  • The proposed first-in-human study of XMT-2056 will be a Phase 1 open-label study of XMT-2056 in previously treated patients with advanced/recurrent solid tumors expressing HER2. The XMT-2056 monotherapy trial will consist of dose escalation (DES) and exp

    Learn More

  • Study 849-001 is a multi-center Phase 1/2 multiple expansion cohort trial evaluating the safety PK metabolites PD and clinical activity/efficacy of MRTX849 in patients with advanced solid tumor malignancies with KRAS G12C mutation. This protocol is d

    Learn More
View All Research Studies (19)

Read All Publications (23)